|
|
Blood, 15 July 2006, Vol. 108, No. 2, pp. 515-517.
Prepublished online as a Blood First Edition Paper on March 28, 2006; DOI 10.1182/blood-2005-11-4571.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Brief report
FVIII production by human lung microvascular endothelial cells
Marc Jacquemin,
Arne Neyrinck,
Maria Iris Hermanns,
Renaud Lavend'homme,
Filip Rega,
Jean-Marie Saint-Remy,
Kathelijne Peerlinck,
Dirk Van Raemdonck, and
Charles James Kirkpatrick
From the Center for Molecular and Vascular Biology, University of Leuven, Belgium; Institute of Pathology, Johannes Gutenberg University, Mainz, Germany; and the Laboratory for Experimental Thoracic Surgery, Katholieke Universiteit Leuven, Belgium.
While extrahepatic factor VIII (FVIII) synthesis suffices for hemostasis, the extrahepatic production sites are not well defined. We therefore investigated the ability of the human lungs to produce FVIII. Lungs from heart-beating donors who were declined for transplantation were perfused and ventilated in an isolated reperfusion model for 2 hours. A progressive accumulation of FVIII and von Willebrand factor (VWF) was recorded in the perfusion medium in 3 of 4 experiments. By contrast, factor V, fibrinogen, and immunoglobulin G (IgG) levels remained constant during the perfusion period, indicating that the accumulation of FVIII and VWF was not due to diffusion from the intercellular medium into the vascular system. Purified human lung microvascular endothelial cells produced FVIII during at least 2 passages in vitro. Altogether, these data identify the lung endothelial cells as a FVIII production site in humans.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Factor VIII biosynthesis: new inspirations?
- Jay Lozier
Blood 2006 108: 414-415.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
N. Yadav, S. Kanjirakkuzhiyil, S. Kumar, M. Jain, A. Halder, R. Saxena, and A. Mukhopadhyay
The therapeutic effect of bone marrow-derived liver cells in the phenotypic correction of murine hemophilia A
Blood,
November 12, 2009;
114(20):
4552 - 4561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Madeira, M. E. Layman, R. E. de Vera, P. A. Fontes, and M. V. Ragni
Extrahepatic factor VIII production in transplant recipient of hemophilia donor liver
Blood,
May 21, 2009;
113(21):
5364 - 5365.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. De Meyer, H. Deckmyn, and K. Vanhoorelbeke
von Willebrand factor to the rescue
Blood,
May 21, 2009;
113(21):
5049 - 5057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Haberichter
VWF and FVIII: the origins of a great friendship
Blood,
March 26, 2009;
113(13):
2873 - 2874.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lacroix-Desmazes, A.-M. Navarrete, S. Andre, J. Bayry, S. V. Kaveri, and S. Dasgupta
Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A
Blood,
July 15, 2008;
112(2):
240 - 249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Aird
Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Circ. Res.,
February 2, 2007;
100(2):
174 - 190.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|